December 2013
|Volume 13 Issue 12
Editorial Staff
Clinical EditorBradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn
Editorial Correspondence
Jodie Elrod, Managing Editor, EP Lab DigestHMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791
Fax: (866) 488-8273
Email: jelrod@hmpglobal.com
The co-authors were the first registered cardiovascular specialist assistants (RCSAs) whose credentials were “grandfathered” in 2010 to undergo training to become certified cardiovascular medical simulation trainers (CTAEs).
Lack of knowledge of a persistent left superior vena cava can bring serious, adverse complications, if a team does not become aware of it in a timely fashion.
This fall, the Parkview Heart Institute became the first institution in the state of Indiana to implant Boston Scientific’s S-ICD® System for the prevention of life-threatening ventricular arrhythmias.
In this interview we speak with Naser Partovi, Founder and CEO of Sanitas Inc., about the Wellaho™ Personalized Outpatient Management System and the Family Healthware™ service.
In this monthly update, we learn about the 8th Annual Educational Conference of the Wisconsin Chapter of the SICP, which was held November 8 and 9.
Did you miss the American Heart Association’s Scientific Sessions 2013? Included here are a few of the clinical news highlights from the conference.
Mohit K. Chawla, MD, FHRS, FACC, FACP et al present a case study that demonstrates the procedural supplies, techniques, and methods that will facilitate a focal RF ablation procedure while utilizing the Achieve mapping catheter.
This month we check out the EP program in Camp Hill, Pennsylvania
EP Lab Digest® speaks with Nancy Lurker, CEO of PDI, Inc. about CardioPredict™, a molecular diagnostic test developed by Transgenomic, Inc. The test identifies a patient’s specific genes that will influence the effectiveness and safety of many common…
Dr. Ruff discusses the North American Thrombosis Forum’s (NATF) Atrial Fibrillation Action Initiative, which was created to identify multidisciplinary best practices for stroke prevention in atrial fibrillation.